Dapiprazole
From Wikipedia, the free encyclopedia
Not to be confused with Aripiprazole.
![]() |
|
Clinical data | |
---|---|
AHFS/Drugs.com | Consumer Drug Information |
MedlinePlus | a601043 |
Pregnancy category |
|
Routes of administration |
Topical (eye drops) |
ATC code | S01EX02 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | Negligible when administered topically |
Identifiers | |
|
|
CAS Number | 72822-12-9 ![]() |
PubChem (CID) | 3033538 |
IUPHAR/BPS | 7155 |
DrugBank | DB00298 ![]() |
ChemSpider | 2298190 ![]() |
UNII | 5RNZ8GJO7K ![]() |
KEGG | D07775 ![]() |
ChEBI | CHEBI:51066 ![]() |
ChEMBL | CHEMBL1201216 ![]() |
Chemical and physical data | |
Formula | C19H27N5 |
Molar mass | 325.451 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
Dapiprazole (Rev-Eyes) is an alpha blocker. It is used to reverse mydriasis after eye examination.[1]
References[edit]
- ^ Doughty, Michael J.; Lyle, William M. (May 1992). "A Review of the Clinical Pharmacokinetics of Pilocarpine, Moxisylyte (Thymoxamine), and Dapiprazole in the Reversal of Diagnostic Pupillary Dilation". Optometry & Vision Science. 69 (5).
![]() |
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |